NYSEMKT:GLQ
Clough Global Equity Fund Stock News
$6.63
+0.0200 (+0.303%)
At Close: May 17, 2024
Clough Global Equity Fund Declares A Monthly Cash Distribution Of $….–…48 Per Share
12:00am, Friday, 08'th Nov 2019Clough Global Equity Fund Announces Preliminary Results of Rights Offering
12:00am, Saturday, 24'th Aug 2019
Clough Global Equity Fund (the “Fund”) is pleased to announce the successful completion of its rights offering, and the preliminary results thereof. The Fund anticipates that it will issue a tota
Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018
12:00am, Wednesday, 21'st Nov 2018Stocks Which Set New 52-Week Low Yesterday, Mon., Nov. 19, 2018
12:00am, Tuesday, 20'th Nov 2018Stocks Which Set New 52-Week Low Yesterday, Thurs., Nov. 16, 2018
12:00am, Friday, 16'th Nov 2018Stocks Which Set New 52-Week High Yesterday, September 17th
12:00am, Tuesday, 18'th Sep 2018Stocks That Made New 52-Week Highs Yesterday, September 6th
12:00am, Friday, 07'th Sep 2018Stocks Which Set New 52-Week High Yesterday, August 29th
12:00am, Thursday, 30'th Aug 2018Stocks Which Set New 52-Week High Yesterday, August 28th
12:00am, Wednesday, 29'th Aug 2018Stocks Which Set New 52-Week High Yesterday, August 14th
12:00am, Wednesday, 15'th Aug 2018Apellis Pharmaceuticals Raises $60M in Series E Financing |FinSMEs
01:16pm, Thursday, 10'th Aug 2017
Apellis Pharmaceuticals, Inc., a Lousiville, Ky.-based clinical-stage biopharmaceutical company developing a platform of novel therapeutic compounds for the treatment of autoimmune diseases, closed a
Sienna Biopharmaceuticals Completes $40M Series B Financing |FinSMEs
02:40pm, Monday, 24'th Apr 2017
Sienna Biopharmaceuticals, Inc., a Westlake Village, Calif.-based clinical stage medical dermatology and aesthetics company, completed a $40m Series B financing. The round was led by existing investor
